High-pressure-mediated dissociation of immune complexes demonstrated in model systems
Author(s) -
Charles Cheung,
David J. Green,
Gerald J. Litt,
James A. Laugharn
Publication year - 1998
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1093/clinchem/44.2.299
Subject(s) - hydrostatic pressure , antigen , antibody , dissociation (chemistry) , chemistry , antigen antibody complex , immune system , glycoprotein , high pressure , immune complex , prostate specific antigen , biophysics , chromatography , microbiology and biotechnology , immunology , biochemistry , biology , medicine , prostate , organic chemistry , thermodynamics , physics , cancer
The use of pressure to disrupt immune complexes was demonstrated in two model systems: prostate-specific antigen (PSA) and anti-PSA antibody; and epiglycanin, a mucin glycoprotein, and an antibody specific to that protein. Dissociation of the anti-PSA antibody from the immobilized PSA antigen was observed when pressures of 415 MPa and 550 MPa (1 MPa approximately 144 psi) were applied at room temperature (approximately 21 degrees C). Application of pressures ranging from 140 MPa to 550 MPa resulted in dissociation of antibody from epiglycanin. In both cases, the rebinding of dissociated antibody to immobilized antigen indicated that the effect of high pressure on the binding of the immune complexes was reversible. These findings suggest that application of high hydrostatic pressure has the potential to be used to significantly improve the sensitivity and specificity of clinical assays.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom